Literature DB >> 33570637

Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.

Fumiyo Maekawa1, Chiyuki Kishimori1, Miho Nakagawa1, Kayo Takeoka1, Katsuhiro Fukutsuka1, Masahiko Hayashida1, Futoshi Iioka2, Masakazu Fujimoto3,4, Kengo Takeuchi5,6,7, Hirokazu Nakamine8, Hitoshi Ohno1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33570637      PMCID： PMC7805338          DOI： 10.1182/bloodadvances.2020003417

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  22 in total

1.  VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.

Authors:  Dirk Kienle; Alexander Kröber; Tiemo Katzenberger; German Ott; Elke Leupolt; Thomas F E Barth; Peter Möller; Axel Benner; Annett Habermann; Hans Konrad Müller-Hermelink; Martin Bentz; Peter Lichter; Hartmut Dōhner; Stephan Stilgenbauer
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

2.  The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.

Authors:  Julia Slotta-Huspenina; Ina Koch; Laurence de Leval; Gisela Keller; Margit Klier; Karin Bink; Marcus Kremer; Mark Raffeld; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?

Authors:  William D Marrero; Alexis Cruz-Chacón; Fernando Cabanillas
Journal:  Leuk Lymphoma       Date:  2018-02-07

4.  Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.

Authors:  Joshua R Menke; George Vasmatzis; Stephen Murphy; Lin Yang; David M Menke; Han W Tun; Rebecca L King; Stephanie A Smoley; Rhett P Ketterling; William R Sukov
Journal:  Hum Pathol       Date:  2017-01-27       Impact factor: 3.466

5.  New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.

Authors:  David W Scott; Pau Abrisqueta; George W Wright; Graham W Slack; Anja Mottok; Diego Villa; Pedro Jares; Hilka Rauert-Wunderlich; Cristina Royo; Guillem Clot; Magda Pinyol; Merrill Boyle; Fong Chun Chan; Rita M Braziel; Wing C Chan; Dennis D Weisenburger; James R Cook; Timothy C Greiner; Kai Fu; German Ott; Jan Delabie; Erlend B Smeland; Harald Holte; Elaine S Jaffe; Christian Steidl; Joseph M Connors; Randy D Gascoyne; Andreas Rosenwald; Louis M Staudt; Elias Campo; Lisa M Rimsza
Journal:  J Clin Oncol       Date:  2017-03-14       Impact factor: 44.544

6.  A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene.

Authors:  H Komatsu; S Iida; K Yamamoto; C Mikuni; M Nitta; T Takahashi; R Ueda; M Seto
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

7.  3'UTR mediated regulation of the cyclin D1 proto-oncogene.

Authors:  Anagha Deshpande; Alessandro Pastore; Aniruddha J Deshpande; Yvonne Zimmermann; Grit Hutter; Marc Weinkauf; Christian Buske; Wolfgang Hiddemann; Martin Dreyling
Journal:  Cell Cycle       Date:  2009-11-03       Impact factor: 4.534

8.  Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation.

Authors:  H Komatsu; K Yoshida; M Seto; S Iida; T Aikawa; R Ueda; C Mikuni
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

9.  t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.

Authors:  Ingram Iaccarino; Lamis Afify; Sietse M Aukema; Katharina Reddemann; Philipp Schütt; Martin Flür; Wolfram Klapper
Journal:  Haematologica       Date:  2018-05-17       Impact factor: 9.941

10.  Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.

Authors:  I Wlodarska; P Meeus; M Stul; L Thienpont; E Wouters; L Marcelis; H Demuynck; J-L Rummens; V Madoe; A Hagemeijer
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.